US Stock MarketDetailed Quotes

ALZN Alzamend Neuro

Watchlist

0.8935
+0.0415+4.87%

Trading Feb 26 10:43 ET

4.85MMarket Cap-0.15P/E (TTM)

Alzamend Neuro Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alzamend Neuro Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 0.000	--
--	2025/Q3	-- / 0.000	--
--	2025/Q2	0.000 / 0.000	--
--	2025/Q1	0.000 / 0.000	--
--	2024/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 0.000--

--2025/Q3-- / 0.000--

--2025/Q20.000 / 0.000--

--2025/Q10.000 / 0.000--

--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Alzamend Neuro Earnings Reports

Alzamend Neuro | 8-K: Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Dec 12, 2024 16:37 ET

Alzamend Neuro | 10-Q: Q2 2025 Earnings Report

Dec 11, 2024 16:36 ET

Alzamend Neuro | 10-Q: Q1 2025 Earnings Report

Sep 11, 2024 16:36 ET

Alzamend Neuro | 10-K: FY2024 Annual Report

Jul 30, 2024 22:20 ET